BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TGI-5 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of TGI-5\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07376707-2764@assetmemo.bio
DTSTAMP:20261121T005808Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:TGI-5: Phase 1 readout est. (NCT07376707)
DESCRIPTION:TGI-5\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Phase 1
  Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjec
 ts With Locally Advanced/Metastatic Solid Tumors\nEstimated primary comple
 tion: 31 October 2027. This is a ClinicalTrials.gov estimate\, not a confi
 rmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dru
 g/tgi-5#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT07376707
URL:https://assetmemo.bio/drug/tgi-5#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
